All sponsors

Shionogi $4507.T

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-32
RECRUITING6
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO67%

Delay Index: of 6 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +13.5 months). See all sponsors →

Open Shionogi on the live radar map → 📅 $4507.T readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
S-337395
NCT07214571
P2RecruitingRespiratory Syncytial Virus Infections1922026-12-30
Sivopixant
NCT06776432
P2Active, not recruitingSleep Apnea602026-12-31 (+13 mo)
Secutrelvir
NCT07746544
P3RecruitingCOVID-1912002027-07-31
S-606001
NCT07123155
P2RecruitingPompe Disease452027-08-08
BPN14770
NCT06717438
P2Active, not recruitingJordan's Syndrome; PPP2R5D Neurodevelopmental Disorder302027-12-31 (+21 mo)
aCCeleR8-001
NCT05101070
P1/2RecruitingSolid Tumors2822028-05-31 (+14 mo)
Naldemedine
NCT05588323
P1/2RecruitingOpioid-Induced Constipation (OIC)242028-06-15 (+46 mo)
Secutrelvir
NCT07743580
P3RecruitingSARS-CoV-220002028-06-30
S-606001
NCT07750990
P2Not yet recruitingPompe Disease602028-08-31